NDC 51662-1218
DIPHENHYDRAMINE HCI
Diphenhydramine Hci
DIPHENHYDRAMINE HCI is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Diphenhydramine Hydrochloride.
| Product ID | 51662-1218_7b05c2ef-24ec-f754-e053-2991aa0afbae |
| NDC | 51662-1218 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DIPHENHYDRAMINE HCI |
| Generic Name | Diphenhydramine Hci |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2018-11-19 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA040140 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | DIPHENHYDRAMINE HYDROCHLORIDE |
| Active Ingredient Strength | 50 mg/mL |
| Pharm Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |